IP Library Granted Patent US 8,440,613
Granted Patent B2
US 8,440,613 · App. 13/000,871 · Granted May 14, 2013

Controlling diseases caused by trichomonadida

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,613
App. No.
13/000,871
Granted
May 14, 2013
Kind
B2
Abstract

The present invention relates to the use of nifurtimox for the treatment of diseases caused by trichomonads, such as, for example, histomoniasis, in particular in turkeys.

Claims (20)

1. A method of treating a disease caused by a Trichomonadida species in an animal comprising administering to the animal in need thereof a pharmaceutical formulation comprising nifurtimox.

2. A method of treating a disease caused by a Histomonadin an animal comprising administering to the animal in need thereof a pharmaceutical formulation comprising nifurtimox.

3. The method of claim 2 , wherein the Histomonad is Histomonas meleagridis.

4. The method of claim 1 , wherein the Trichomonadida species is of the genus Trichomonas.

5. The method of claim 1 , wherein the Trichomonadida species is of the genus Tritrichomonas.

6. The method of claim 1 , wherein the pharmaceutical formulation further comprises an anthelmintic.

7. The method of claim 6 , wherein the anthelmintic comprises a cyclodepsipeptide.

8. The method of claim 3 wherein the cyclodepsipeptide comprises a compound selected from the group consisting of PF1022, PF1022A, PF1022-221, salts thereof, and solvates thereof.

9. The method of claim 6 , wherein the anthelmintic comprises a benzimidazole or probenzimidazole.

10. The method of claim 1 , wherein the animal is poultry.

11. The method of claim 1 , wherein the pharmaceutical formulation comprising nifurtimox is administered orally to the animal.

12. The method of claim 11 , wherein the pharmaceutical formulation comprising nifurtimox is administered to the animal by mixing into the animal's feed or drinking water.

13. The method of claim 2 , wherein the pharmaceutical formulation further comprises an anthelmintic.

14. The method of claim 13 , wherein the anthelmintic comprises a cyclodepsipeptide.

15. The method of claim 14 wherein the cyclodepsipeptide comprises a compound selected from the group consisting of PF1022, PF1022A, PF1022-221, salts thereof, and solvates thereof.

16. The method of claim 13 , wherein the anthelmintic comprises a benzimidazole or probenzimidazole.

17. The method of claim 2 , wherein the animal is poultry.

18. The method of claim 2 , wherein the animal is a turkey.

19. The method of claim 2 , wherein the pharmaceutical formulation comprising nifurtimox is administered orally to the animal.

20. The method of claim 19 , wherein the pharmaceutical formulation comprising nifurtimox is administered to the animal by mixing into the animal's feed or drinking water.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2013
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030127/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2011
From: HARDER, ACHIM; GREIF, GISELA; FROYMAN, ROBRECHT
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 025586/0245 →